Enliven Therapeutics Inc. Strategic Asset Allocation Index
Enliven Therapeutics Inc. strategic asset allocation index. Enliven Therapeutics Inc. (ELVN) has a Strategic Asset Allocation Index of 0.5% as of June 2023. Strategic assets (PP&E of $1.34 Million plus long-term investments of $-) total $1.34 Million, measured against net assets of $278.99 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Enliven Therapeutics Inc. tangible book value ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Enliven Therapeutics Inc. (2020–2021)
Strategic asset allocation index of Enliven Therapeutics Inc. from 2020 to 2021. This chart shows how Enliven Therapeutics Inc.'s Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2021. As of June 2023, the index stands at 0.5%, representing strategic assets of $1.34 Million against net assets of $278.99 Million USD.
Enliven Therapeutics Inc. Strategic Asset Allocation Index by Year (2020–2021)
Enliven Therapeutics Inc. strategic asset allocation index by year from 2020 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Enliven Therapeutics Inc. from 2020 to 2021, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Enliven Therapeutics Inc..
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.9% | $954.00K | $954.00K | $- | $106.86 Million | ▲ +0.4 pp |
| 2020 | 0.5% | $416.00K | $416.00K | $- | $84.44 Million | — |